Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TBR Dental is a French dental implant and oral rehabilitation company focused on implantology products for dentists, surgeons, and dental laboratories. The company is best known for its patented Z1 tissue-level dental implant, which combines a pure titanium implant body with a zirconia collar designed to support soft-tissue integration and esthetic outcomes. TBR also markets bone-level implants, implant-supported prosthetic components, surgical and prosthetic instruments, guided-surgery solutions, CAD/CAM-related offerings, and synthetic bone graft products such as Graftek Neo. The business operates commercially across multiple countries and positions itself as an inventor-manufacturer with a strong focus on premium implant systems and clinical education. It is a healthcare company, but not a drug-development biotech or pharma company; its activities are centered on dental devices and regenerative dental materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TBR Dental.